THRIVE in Pediatric Laryngeal Microsurgery

Transnasal High-flow rapid-insufflation ventilatory exchange (THRIVE) has been shown to benefit oxygenation, ventilation and upper airway patency in a range of clinical scenarios, however its use in spontaneously breathing pediatric patients undergoing tubeless airway surgery has not been described. This is a physiologic study that evaluates the feasibility of THRIVE during pediatric airway surgery under self-respiration.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Laryngoscopy

Age range

Up to 6 year

Sex eligibility

All sexes

Study type

Observational

Primary location

SNUH

Seoul, Jongro Gu, 15710, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

pediatric patients undergoing laryngeal microsurgery with spontaneous ventilation

Exclusion criteria

Severe gastrointestinal reflux disease Neuromuscular disease Central hypoventilation

Treatment and study plan

Primary outcomes

number of low saturation events

Time frame: Intraoperative

oxygen saturation decrease lower than 90%

Sponsors and collaborators

Lead sponsor

Seoul National University Hospital

Other

Registry information

Official study title

The Effects of Transnasal Humidified Rapid Insufflation Ventilator Exchange (THRIVE) on the Oxygenation in Pediatric Patients Under Tubeless Airway Surgery - a Physiologic Study

Important dates

Study start: 2017
Primary completion: 2019
Study completion: 2019
First posted: Aug 8, 2017
Registry last updated: Apr 21, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed